United Kingdom· GB-APID-41535911000001104
Bivalirudin 250mg powder for concentrate for solution for infusion vials
A bivalirudin product containing bivalirudin, registered in United Kingdom by Kensington Pharma Ltd. The same ATC class is registered in 11 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Bivalirudin is registered in 11 of 19 countries.
Countries holding a registration under ATC B01AE06 (bivalirudin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 5 of them publish a price we can compare per daily dose
Bivalirudin · ATC B01AE06
11 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bivalirudin
- Manufacturer
- Kensington Pharma Ltd
- Country
- United Kingdom (GB)
- ATC code
- B01AE06
- ATC class
- Bivalirudin
- Defined daily dose
- 0.25 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060467000390
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
148 interactions on record for bivalirudin.
Graded by severity as the source publishes them — 63 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Bivalirudin · interactions on record
148 records
- 63 severe
- 85 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Bivalirudin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAngioxOrifarm Oy
- BelgiumAngiox 250 mgThe Medicines Company
- SpainBIVALIRUDINA ACCORD 250 MG DE POLVO PARA CONCENTRADO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGAccord Healthcare S.L.U.
- PolandBiwalirudyna AccordAccord Healthcare Polska Sp. z o.o.
- SwedenBivalirudin Reig Jofre 250 mg Pulver till koncentrat till injektions-/infusionsvätska, lösningBioglan AB
- United StatesbivalirudinSlate Run Pharmaceuticals, LLC
- CanadaANGIOMAXSANDOZ CANADA INCORPORATED
- NetherlandsBivalirudine Accord 250 mg poeder voor concentraat voor oplossing voor injectie/infusieAccord Healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Bivalirudin Accord
- Belgium · Bivalirudin Accord Healthcare, Bivalirudin Hikma
- Germany · Bivalirudin Accord
- Denmark · Bivalirudin Reig Jofre
- Spain · Bivalirudina Hikma, Bivalirudina Sala
- Finland · Bivalirudin Bioglan
- France · Bivalirudine Accord, Bivalirudine Hikma
- Italy · Bivalirudina Accord, Bivalirudina Hikma
- Netherlands · Bivalirudine Accord, Bivalirudine Hikma
- Poland · Biwalirudyna Accord
- Portugal · Bivalirudina Accord, Bivalirudina Hikma
- Sweden · Bivalirudin Reig Jofre
- Slovenia · Bivalirudin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2244b52-5756-4c6c-8a89-beba7455761d GET /v1/drugs/e2244b52-5756-4c6c-8a89-beba7455761d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41535911000001104",
"desc": "Bivalirudin 250mg powder for concentrate for solution for infusion vials (Kensington Pharma Ltd)",
"form": "Powder for solution for infusion",
"vpid": "8578811000001108",
"source": "dmd",
"vtm_id": "774885001",
"strength": "250 mg",
"substance": "Bivalirudin",
"ingredient": "Bivalirudin",
"supplier_code": "31307011000001102"
}See everything about bivalirudin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.